Showing results (351-360 of 6,286) with videos related to
Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|February 28, 2001
Effects of current therapeutic interventions on insulin resistanceM KobayashiDiabetes, Obesity & Metabolism|February 28, 2001
The relation between insulin resistance and cardiovascular complications of the insulin resistance syndromeK RettDiabetes, Obesity & Metabolism|February 28, 2001
Non-enzymatic glycation of lens proteins and haemoglobin-inhibition by pyruvate: an in-vivo studyP S Devamanoharan, A H Ali, S D VarmaDiabetes, Obesity & Metabolism|February 28, 2001
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled studyJ Patel, R J Anderson, E B RappaportDiabetes, Obesity & Metabolism|February 28, 2001
Dissociation between Fas expression and induction of apoptosis in human islets of LangerhansA C Loweth, K Watts, S C McBain, et al.Diabetes, Obesity & Metabolism|February 28, 2001
Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albuminA C Desfaits, O Serri, G RenierDiabetes, Obesity & Metabolism|February 28, 2001
Lipid lowering explains the insulin sensitivity enhancing effects of a thiazolidinedione, 5-(4-(2-(2-phenyl-4-oxazolyl)ethoxy)benzyl)-2,4 thiazolidinedioneF E Yakubu-Madus, T W Stephens, W T JohnsonDiabetes, Obesity & Metabolism|February 28, 2001
Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetesA Katsuki, Y Sumida, K Murata, et al.Diabetes, Obesity & Metabolism|August 16, 2002
Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazolRichard DonnellyDiabetes, Obesity & Metabolism|August 16, 2002
Treating peripheral arterial disease in patients with diabetesNorbert Hittel, Richard DonnellyPageof 629